慢性间歇性囊炎和膀疼痛综合征的病理机制和当前治疗方法
Wan-Ru Yu1,2,3, Jia-Fong Jhang2, Yuan-Hong Jiang2
1Department of Nursing, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 970, Taiwan.
Biomedicines
|September 28, 2024
概括
间歇性囊炎/膀疼痛综合征 (IC/BPS) 是一种导致膀疼痛和频繁排尿的慢性疾病. 有效的治疗需要识别不同的患者类型和定制疗法,包括新的方法,以获得更好的结果.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 疼痛管理 疼痛管理
- 胃肠病学 胃肠病学
背景情况:
- 间歇性囊炎/膀疼痛综合征 (IC/BPS) 呈现为慢性膀疼痛,排尿频率和夜尿,显著影响生活质量.
- 症状与其他疾病 (如过度活动的膀和细菌性囊炎) 重叠,往往导致误诊和治疗延迟.
- IC/BPS包括亨纳的 (HIC) 和非亨纳的 (NHIC) 亚型,每个亚型都有独特的病理生理学,涉及尿路功能障碍,炎症和中央敏感性.
研究的目的:
- 审查尿液生物标志物,膀炎症和糖氨酸甘油在IC/BPS病原体中的作用.
- 探索IC/BPS的各种治疗方式,强调个性化策略.
- 强调多式联络方法的重要性,包括理疗和心理支持.
主要方法:
- 关于IC/BPS病原和治疗的当前文献的审查.
- 对诊断挑战和差异诊断的讨论.
- 分析各种治疗干预措施,从传统到创新.
主要成果:
- 病原发生涉及泌尿器功能障碍,炎症,中心敏感化,以及可能改变的葡萄糖胺氨基酸层.
- 治疗方案包括糖氨基糖补充,肉毒素A,富血小板血,冲击波疗法,免疫抑制和口服类固醇.
- 综合护理包括盆地理疗,膀治疗和精神病学咨询,可以改善患者的治疗结果.
结论:
- 了解IC/BPS表型和病理生理学对于定制治疗策略至关重要.
- 建议采用多模式治疗方法,以解决炎症,泌尿道完整性和中央敏感性.
- 需要进一步研究病理机制和各种治疗方案,以推进IC/BPS护理.
相关概念视频
01:25Urinary Tract Infection II: Pathophysiology
2
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
2
01:30Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
2
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
2
01:21Drugs for Treatment of Constipation-Predominant IBS
140
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
140
01:26Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
2
Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
2
01:17Irritable Bowel Syndrome I: Introduction
254
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
254
01:17Drugs for Treatment of Diarrhea-Predominant IBS
151
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
151